2021
DOI: 10.3389/fcimb.2021.716563
|View full text |Cite
|
Sign up to set email alerts
|

Taste Dysfunction and Long COVID-19

Abstract: Chemosensory dysfunctions including anosmia, hyposmia, ageusia, and hypogeusia constitute one of the chief symptoms of SARS-CoV2 infection. Meta-analyses suggest that the prevalence of olfactory dysfunction ranged between 41.0-61.0% and that of gustatory dysfunction between 38.2-49.0% in COVID-19. Indeed, self-reported loss of smell and taste has been observed to be more prognostic than other symptoms including fatigue, fever, or cough in predicting symptomatic infection (Agyeman et al., 2020;Mastrangelo et al… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
15
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 20 publications
(20 citation statements)
references
References 45 publications
(60 reference statements)
2
15
0
Order By: Relevance
“…Chemosensory dysfunctions, especially hyposmia, anosmia, hypogeusia, and ageusia, are one of the major symptoms of SARS-CoV2 infection ( Srinivasan, 2021 ). Self-reported loss of smell and taste is a better prognosticator than other symptoms such as cough, fatigue, or fever for predicting symptomatic infection ( Mastrangelo et al, 2021 ).…”
Section: Discussionmentioning
confidence: 99%
“…Chemosensory dysfunctions, especially hyposmia, anosmia, hypogeusia, and ageusia, are one of the major symptoms of SARS-CoV2 infection ( Srinivasan, 2021 ). Self-reported loss of smell and taste is a better prognosticator than other symptoms such as cough, fatigue, or fever for predicting symptomatic infection ( Mastrangelo et al, 2021 ).…”
Section: Discussionmentioning
confidence: 99%
“…It follows that the grade severity of the COVID-19 would depend on age and pre-existing diseases, as well as on an over-consumption of stored vitamin D within the body in response to SARS-CoV-2 invasion via RAS/ACEr mechanism. With this concept in mind, it follows that any therapeutic approach should include a flexible approach which previews the use of multiple agents, especially in those individuals at high risk, such as the elderly and patients with metabolic–chronic comorbidities [ 40 , 49 , 50 , 51 , 52 , 53 ].…”
Section: Discussionmentioning
confidence: 99%
“…It was proposed that altered epithelial homeostasis secondary to COVID-19 induces dysbiosis and chronic inflammation. This causes increased exfoliation, and the reduced number of taste receptors could be attributed to persistent dysgeusia in patients with COVID-19 ( 114 ). Persistent olfactory and taste dysfunction significantly worsens patient wellbeing and may cause psychiatric disorders such as depression, anxiety, and cognitive impairment.…”
Section: Methodsmentioning
confidence: 99%